Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A robust phenomenological approach to investigate COVID-19 data for France

View ORCID ProfileQ. Griette, View ORCID ProfileJ. Demongeot, View ORCID ProfileP. Magal
doi: https://doi.org/10.1101/2021.02.10.21251500
Q. Griette
1Univ. Bordeaux, IMB, UMR 5251, F-33400 Talence, France
2CNRS, IMB, UMR 5251, F-33400 Talence, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Q. Griette
J. Demongeot
1Univ. Bordeaux, IMB, UMR 5251, F-33400 Talence, France
2CNRS, IMB, UMR 5251, F-33400 Talence, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for J. Demongeot
P. Magal
1Univ. Bordeaux, IMB, UMR 5251, F-33400 Talence, France
2CNRS, IMB, UMR 5251, F-33400 Talence, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for P. Magal
  • For correspondence: pierre.magal{at}u-bordeaux.fr
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

We provide a new method to analyze the COVID-19 cumulative reported cases data based on a two-step process: first we regularize the data by using a phenomenological model which takes into account the endemic or epidemic nature of the time period, then we use a mathematical model which reproduces the epidemic exactly. This allows us to derive new information on the epidemic parameters and to compute the effective basic reproductive ratio on a daily basis. Our method has the advantage of identifying robust trends in the number of new infectious cases and produces an extremely smooth reconstruction of the epidemic. The number of parameters required by the method is parsimonious: for the French epidemic between February 2020 and January 2021 we use only 11 parameters in total.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

his research was also funded by the Agence Nationale de la Recherche in France (Project name : MPCUII (QG, PM)).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

We do not have anything to do with IRB/oversight body I comfirm the ethical guidelines have been followed

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data were produced

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted February 12, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A robust phenomenological approach to investigate COVID-19 data for France
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A robust phenomenological approach to investigate COVID-19 data for France
Q. Griette, J. Demongeot, P. Magal
medRxiv 2021.02.10.21251500; doi: https://doi.org/10.1101/2021.02.10.21251500
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A robust phenomenological approach to investigate COVID-19 data for France
Q. Griette, J. Demongeot, P. Magal
medRxiv 2021.02.10.21251500; doi: https://doi.org/10.1101/2021.02.10.21251500

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (427)
  • Allergy and Immunology (753)
  • Anesthesia (220)
  • Cardiovascular Medicine (3281)
  • Dentistry and Oral Medicine (362)
  • Dermatology (274)
  • Emergency Medicine (478)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1164)
  • Epidemiology (13337)
  • Forensic Medicine (19)
  • Gastroenterology (896)
  • Genetic and Genomic Medicine (5128)
  • Geriatric Medicine (479)
  • Health Economics (781)
  • Health Informatics (3251)
  • Health Policy (1137)
  • Health Systems and Quality Improvement (1189)
  • Hematology (427)
  • HIV/AIDS (1012)
  • Infectious Diseases (except HIV/AIDS) (14611)
  • Intensive Care and Critical Care Medicine (908)
  • Medical Education (475)
  • Medical Ethics (126)
  • Nephrology (521)
  • Neurology (4898)
  • Nursing (261)
  • Nutrition (725)
  • Obstetrics and Gynecology (879)
  • Occupational and Environmental Health (795)
  • Oncology (2515)
  • Ophthalmology (722)
  • Orthopedics (280)
  • Otolaryngology (346)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (537)
  • Pediatrics (1297)
  • Pharmacology and Therapeutics (548)
  • Primary Care Research (554)
  • Psychiatry and Clinical Psychology (4189)
  • Public and Global Health (7482)
  • Radiology and Imaging (1700)
  • Rehabilitation Medicine and Physical Therapy (1010)
  • Respiratory Medicine (979)
  • Rheumatology (478)
  • Sexual and Reproductive Health (495)
  • Sports Medicine (424)
  • Surgery (545)
  • Toxicology (71)
  • Transplantation (235)
  • Urology (203)